ERJ Open Research

Article	Citations
A comprehensive evaluation of murine and humanex vivocultured alveolar macrophages	145
The long-term effects of insulin use in incident cystic fibrosis-related diabetes: a target trial emulated using longitudinal national registry data	103
The AWESCORE, a patient-reported outcome measure: development, feasibility, reliability, validity and responsiveness for adults with cystic fibrosis	81
Antitrypsin deficiency: still more to learn about the lung after 60 years	78
Diagnosis of pulmonary embolism in patients with haemoptysis: the POPEIHE study	55
Proteins associated with preserved ratio impaired spirometry (PRISm)	51
Achieving adherence to positive airway pressure in commercial drivers using an employer-mandated remote management programme	49
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey	47
Spirometry at different Latin-American altitudes: A Global Lung Function Initiative project	46
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care	40
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients	39
Influence of sex, season and environmental air quality on experimental human pneumococcal carriage acquisition: a retrospective cohort analysis	38
Dysglycaemia among tuberculosis patients without known diabetes in a low-endemic setting	37
Uncontrolled asthma from childhood to young adulthood associates with airflow obstruction	37
Prednisolone for COPD exacerbations: time for a rethink	37
Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance	36
A survey of UK respiratory specialists’ opinion on the management of chronic cough	35
Anodal transcranial direct current stimulation over the right primary somatosensory cortex increases cough reflex sensitivity: a pilot randomised controlled crossover trial	34
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort	33
Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score	31
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough	31
Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality	31
Dual CFTR modulator therapy efficacy in the real world: lessons for the future	31
Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis	28
Triple therapy in COPD: understanding the data	26

Long-term incident severe outcomes in a prospective cohort of non-obese obstructive sleep apnoea patients free of comorbidities at inclusion	26
Clinical impact of routine sleep assessment by peripheral arterial tonometry in patients with COPD	26
Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study	26
ERS International Congress 2022: highlights from the Basic and Translational Science Assembly	25
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation	25
Period and cohort effects: consequences on spirometric lung function in Norway during the 20th century	25
Williams–Campbell syndrome case series and discordant twins	25
Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea	24
Targeted DNase treatment of obstructive lung disease: a pilot randomised controlled trial	24
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry	24
“Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.” Michael R. Loebinger, Stefano Aliberti, Charles Haw	24
Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant trajectory	24
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease	23
The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction	23
Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis	23
The Role of Clamping Before Removal of a Chest Tube in Post-Surgical and Pneumothorax Patients Using Digital Drainage Systems: A Non-inferiority Randomized Trial	23
An observational study ofPseudomonas aeruginosain adult long-term ventilation	23
Artificial intelligence augmentation raises questions about the future of bronchoscopy	22
Myostatin/Smad2/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia	22
Diagnostic delay in bronchiectasis: an Italian perspective	22
Utility of rehabilitation prior to bronchoscopic lung volume reduction:post hocanalysis of the VENT trial	21
The impact of personal and outdoor temperature exposure during cold and warm seasons on lung function and respiratory symptoms in COPD	21
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience	21
High-frequency percussive ventilation in acute respiratory failure	21
Global survey of physician testing practices for nontuberculous mycobacteria	21
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study	20
Risk factors, molecular analysis, and treatment outcomes of amikacin-resistantMycobacterium aviumcomplex pulmonary disease	20
To burn or not to burn: similar effects of different types of prenatal tobacco exposure on infant lung function	20
Effects of seasonality and treatment on COPD clinical outcomes: IMPACTpost hocanalysis	20
Association of DPP-4 inhibitors with respiratory and cardiovascular complications in patients with COPD: A nationwide cohort study	20
Should all patients with COPD be treated with inhaled triple therapy?	19
Alpha-1-Antitrypsin deficiency and increased risk of atrial fibrillation in two large population-based cohorts	19
Navigating family dynamics and ethical considerations in genetic diagnosis of pulmonary arterial hypertension: insights from in-depth semi-structured interviews	19
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis	18
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries	18
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO	18
Safety and feasibility of ultrathin probe transbronchial lung cryobiopsy without balloon blockerviarobotic bronchoscopy in the evaluation of peripheral lung lesions: a retrospective pilot study	18
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea	18
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases	18
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database	18
Chaotic breathing in post-COVID-19 breathlessness: a key feature of dysfunctional breathing can be characterised objectively by approximate entropy	18
Hospitalisation outcomes in pneumococcal-vaccinatedversus-unvaccinated patients with exacerbation of COPD: results from the HOPE COPD Study	18
Changes in fatigue symptoms following an exercise-based rehabilitation programme for patients with long COVID	18
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics	18
COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneity	17
Still no room to breathe: insights on supine lung mechanics from oscillometry in COPD	17
Clinical assessment of balance and functional impairments in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis	17
Oxygen saturation targets for children with respiratory distress: a systematic review	17
Biomarkers of chronic airflow limitation and COPD identified by mass spectrometry	17
Modifiable lifestyle risk factors for sarcoidosis: a nested case–control study	17

Deleterious effect ofP. aeruginosaon F508del-CFTR rescued by Elexacaftor/Tezacaftor/Ivacaftor is clinical-strain dependent in patient-derived nasal cells	17
Evaluation of a screening protocol for telomere biology disorders in individuals with interstitial lung disease undergoing lung transplant evaluation	17
Associations of physical activity and quality of life in parapneumonic effusion patients	17
Developing a self-management package for pulmonary fibrosis: an international Delphi study	17
Time to negative conversion and cardiopulmonary performance in athletes with COVID-19	17
Anxiety and depression in Dutch patients with primary ciliary dyskinesia and their caregivers: associations with health-related quality of life	16
Effect of water- and land-based exercise on lung function in children with post COVID-19 condition: secondary results from a randomized controlled trial	16
Is overreliance on short-acting β2-agonists associated with health risks in the older asthma population?	16
Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study	16
A robust web-based tool to predict viral shedding in patients with Omicron SARS-CoV-2 variants	16
“You can do it yourself and you can do it at your convenience”: internet accessibility and willingness of people with chronic breathlessness to use an internet-based breathlessness self-management int	15
Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation	15
Interstitial lung abnormalities: do symptoms matter?	15
Right ventricular–pulmonary arterial coupling predicts mortality in precapillary pulmonary hypertension	15
Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema	15
Home sleep studies in children with neurodisabilities: success rates and parental perception	15
Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central CT structures	15
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis	15
Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype	15
A worldwide look into long COVID-19 management: an END-COVID survey	15
How to distinguish PPI-refractory from PPI-responsive patients in gastro-oesophageal reflux-induced chronic cough: post-reflux swallow induced peristaltic wave index and mean nocturnal baseline impeda	15
The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma	15
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis	15
No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis	14
Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2	14
Evaluation of spirometry-gated computed tomography to measure lung volumes in emphysema patients	14
Cardiac dysfunction during exercise in young adults with bronchopulmonary dysplasia	14
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?	14
Biologicals in childhood severe asthma: the European PERMEABLE survey on thestatus quo	14
Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19	14
Dupilumab-associated hypereosinophilia in severe asthma	14
A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension	14
Early career member highlights of Assembly 3 Basic and Translational Sciences from the International ERS Congress 2024: The regenerative potential of stem cells in lung diseases	14
Breathing pattern and muscle activity using different inspiratory resistance devices in children with mouth breathing syndrome	14
Intimal granulomatous angiitis in sarcoid pulmonary vasculitis: worth remembering	13
“Influence of physical activity on the prognosis of COPD patients: the HADO.2 score – health, activity, dyspnoea and obstruction”. Cristóbal Esteban, Nere Larrea, Amaia Aramburu, Javier Moraza, Leyre	13
Increased bronchiectasis risk and related risk factors in inflammatory bowel disease: a 10-year Korean national cohort study	13
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension	13
Shorter walk test durations to detect ambulatory oxygen desaturation in interstitial lung disease: an observational cohort study	13
Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin	13
External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension	13
Rapid real-world implementation of pulmonary telerehabilitation: good fortune or COVID-19 luck?	13
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study	13
Possible overdiagnosis of early-stage lung adenocarcinoma among never-smokers in Taiwan	13
Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial	13
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma	13
Effects of Exercise and a Lifestyle App on Sleep-Disordered Breathing, Physical Health, and quality of Life	13
Upper lobe CT imaging features improve prediction of lung function decline in COPD	13
It is time to end our love affair with short-acting β2-agonists in asthma? Yes	13
Reply: Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma	13
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension	13
Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts	12
Benefit−risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis	12
Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients withEGFR-mutated non-small cell lung cancer treated with afatinib	12
De-labelling severe asthma diagnosis: the challenge of DIPNECH	12
Current and novel treatment options for obstructive sleep apnoea	12
Telemonitoring for the follow-up of home noninvasive ventilation: a promising future with ongoing challenges	12
Infant lung function: criteria for selecting tidal flow–volume loops	12
Compartment-specific protein interactions in beryllium lung disease	12
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population	12
Ventricular arrhythmia in heart failure patients with reduced ejection fraction and central sleep apnoea	12
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension	12
Artificial intelligence improves bronchoscopy performance: a randomised crossover trial	12
The impact of the COVID-19 pandemic on pleural infection incidence: a UK multicentre retrospective analysis	12
Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma	12
Predictors of mortality and hospitalised exacerbations in obstructive airway diseases	12
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges	12
The association of weather conditions with day-to-day variability in physical activity in patients with COPD	12
ERS Congress 2024: highlights from the Clinical Techniques, Imaging and Endoscopy Assembly	11
Physical capacity and inactivity in obstructive airway diseases: a “can do, do do” analysis	11
Predictors of invasive mechanical ventilation use in patients with acute decompensated pulmonary hypertension admitted to the intensive care unit	11
Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction	11
Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion	11
Methicillin-Resistant Staphylococcus Aureus and Pulmonary Outcome in People with Cystic Fibrosis: A European Cystic Fibrosis Patient Registry Data Analysis	11
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohort	11
Upper-limb intervalversusconstant-load exercise in patients with COPD: a physiological crossover study	11
Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD	11
Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) – a cohort study	11
Living with chronic cough: experiences, burden and management in interstitial lung disease – a mixed methods study	11
Systemic pro-inflammatory response following bronchoscopic lung volume reduction using endobronchial valves	11

Locus of control and breathlessness: a cross-sectional analysis of 28,730 people	11
Exercise responses and mental health symptoms in COVID-19 survivors with dyspnoea	11
Normal values of respiratory oscillometry in South African children and adolescents	11
Feasibility of using Continuous Positive Airway Pressureviathe ‘LeVe CPAP System’ among Children with Acute Hypoxaemic Respiratory Failure at Mengo Hospital Kampala Uganda: A Mixed Methods stud	11
OSA symptom subtypes and hypoxic burden independently predict distinct cardiovascular outcomes	11
Risk factors and interventions for developing recurrent pneumonia in older adults	10
Noninvasive diagnosis of pulmonary hypertension with hyperpolarised129Xe magnetic resonance imaging and spectroscopy	10
Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review	10
Laboratory and free-living gait performance in adults with COPD and healthy controls	10
Adverse perception of cough in patients with severe asthma: a discrete choice experiment	10
“A pulmonary rehabilitation shared decision-making intervention for patients living with COPD: PReSent: protocol for a feasibility study”. Amy C. Barradell, Linzy Houchen-Wolloff, Noelle Robertson, Hi	10
Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial	10
Age and body mass index affect fit of spirometry Global Lung Function Initiative references in schoolchildren	10
Early benefit of mepolizumab on small airways in severe asthma: insights from IMPOSE study	10
An exploration of clinically meaningful definitions of cough bouts	10
Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years	10
Response to endobronchial valve treatment: it's all about the target lobe	10
Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β1are linked to inflammatory response in sputum of cystic fibrosis patients withPseudomonas aeruginos	10
Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model	10
Diffuse panniculitis in a teenage male with ZZ α1-antitrypsin deficiency	10
Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry	10
Gene expression profile of epithelial–mesenchymal transition in tumours of patients with nonsmall cell lung cancer: the influence of COPD	10
Laryngeal mask airway or high-flow nasal cannulaversusnasal cannula for advanced bronchoscopy: a randomised controlled trial	10
Endobronchial cryobiopsy may shorten the time to cancer diagnosis: a retrospective study	10
Symptomatic smokers without COPD have physiological changes heralding the development of COPD	10
Lung disease in never smokers with severe alpha-1 antitrypsin deficiency: The EARCO Registry	10
Efficacy of interventions to alter measures of fat-free mass in people with COPD: a systematic review and meta-analysis	10
High-flow oxygen therapyversusnoninvasive ventilation: a randomised physiological crossover study of alveolar recruitment in acute respiratory failure	10
Longitudinal change in ultrasound-derived rectus femoris cross-sectional area in COPD	10
Inhaled nitric oxide for the treatment of COVID–19: an open-label, parallel, randomised controlled trial	10
Obstructive sleep apnoea-related respiratory events and desaturation severity are associated with the cardiac response	10
ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly	10
Exhaled volatile organic compounds associated with risk factors for obstructive pulmonary diseases: a systematic review	10
Hypercoagulation in COPD: the clot thickens	10
BOS-318 treatment enhances elexacaftor–tezacaftor–ivacaftor-mediated improvements in airway hydration and mucociliary transport	10
Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids	10
The Palestinian primary ciliary dyskinesia population: first results of the diagnostic and genetic spectrum	10
The effect of exacerbations on lung density in α1-antitrypsin deficiency	10
Factors most strongly associated with breathlessness in a population aged 50–64 years	10
Predicting Outcomes after Hospitalisation for COPD Exacerbation Using Machine Learning	9
Effects of acetazolamide on sleep disordered breathing in pulmonary vascular disease: a randomised controlled trial	9
Bronchiectasis: moving from an orphan disease to an unpleasant socioeconomic burden	9
Clinical relevance of lung function trajectory clusters in middle-aged and older adults	9
Treatable Traits in Chronic Cough: a Prospective Evaluation for Predicting Cough Persistence	9
Past asthma exacerbation in children predicting future exacerbation: a systematic review	9
The effects of dual IQOS and cigarette smoke exposure on airway epithelial cells: implications for lung health and respiratory disease pathogenesis	9
Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale	9
Telemedicine and virtual respiratory care in the era of COVID-19	9
Feasibility of comprehensive genotyping specimens from radial endobronchial ultrasonography and electromagnetic navigation bronchoscopy	9
Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial	9
Post-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in the COPD population	9
Post-viral lung diseases: the microbiota as a key player	9
A new variant in theZCCHC8gene: diverse clinical phenotypes and expression in the lung	9
Poor performance of paired tests of latent tuberculosis in highly immune-compromised individuals exposed to multidrug-resistant tuberculosis: time for new diagnostic markers	9
Peeping at COPD through the keyhole: time to broaden the view to the complexity of the disease by the heterogeneity of symptoms	9
Beyond type 2 asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease	9
Validation and Cross-Cultural Insights of the French Translation of the Severe Asthma Questionnaire	9
Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study	9
Qualitative assessment of sensations and triggers in chronic cough	9
Performance of two portable exhaled nitric oxide fraction devices compared to a “gold standard” chemiluminescence device	9
Clinical and prognostic role of tricuspid regurgitation in incident patients with pulmonary arterial hypertension	9
Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study	9
Multidisciplinary rehabilitation in intensive care for COVID-19: randomised controlled trial	9
Swallow patterns associated with aspiration in COPD: a prospective analysis	9
Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study	9
Utility of Diaphragm Dome Height as a Marker of Operational Lung Volume Changes, Disease Burden and Exacerbations in Patients with Mild-to-Moderate COPD: An Observational Study Within the CanCOLD Coho	9
NKX2.1mutation revealed by a lymphoid interstitial pneumonia in an adult with rheumatoid arthritis	9
End-tidal carbon dioxide tension is a reliable surrogate of arterial carbon dioxide tension across different oxygen, carbon dioxide and barometric pressures	9
Exercise intolerance in post-coronavirus disease 2019 survivors after hospitalisation	9
A cystic and bullous lung disease associated with a PIK3CA-related overgrowth syndrome	9
Venous thromboembolism associated with severe dyspnoea and asthma in 102 792 adults	9
Reference equations for quadriceps strength, endurance and power: a multicentre study	9
Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE	9
Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study	9
ERS Congress 2024: highlights from the Respiratory Intensive Care Assembly	9
Delayed airway epithelial repair is correlated with airway obstruction in young adults born very preterm	9
ERS International Congress 2023: highlights from the Respiratory Intensive Care Assembly	9
Diagnosis of primary ciliary dyskinesia: discrepancy according to different algorithms	9
Variability in P2X receptor composition in human taste nerves: implications for treatment of chronic cough	9
Clinical Significance of Respiratory Bacteria and Mycobacteria Isolates in Adult Bronchiectasis in Taiwan	9
Ethnic variation in asthma healthcare utilisation and exacerbation: systematic review and meta-analysis	9
Does COVID-19 vaccination increase the risk of interstitial lung disease at a population level?	9
Assessment of factors and interventions towards therapeutic adherence among persons with non-cystic fibrosis bronchiectasis	9
Outcomes and measures in studies of techniques to promote secretion clearance in individuals with neuromuscular conditions: a scoping review	8
Front-door thoracic ultrasound in patients with community-acquired pneumonia to diagnose and predict pleural infection: a prospective study	8
How have we measured trial outcomes of asthma attack treatment? A systematic review	8
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV): protocol and cohort profile	8
Understanding patient experience of chronic cough in interstitial lung disease	8
Group-based pulmonary telerehabilitation is feasible, safe, beneficial and well-received in patients who have been hospitalised with COVID-19	8
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD	8
The interrelationship of chronic cough and depression: a prospective population-based study	8
Subcutaneous octreotide as a therapeutic option for refractory chronic cough: subjective response pattern and adverse effects from a retrospective single-centre case series	8
COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial	8
Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial	8
Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist	8